Greg Lucier is Chairman and CEO of Life Technologies.  The company is a leading global innovator that has made strategic investments in growing markets like synthetic biology and molecular medicine, which have set the stage for Life Technologies to remain a frontrunner in scientific innovation that will have an impact on human health and the environment.  Mr. Lucier’s leadership has been pivotal in forging Life Technologies’ path of success into new areas of applied biology.  Mr Lucier serves on the Board of Directors at Synthetic Genomics, Inc. and CareFusion Corporation, and serves as Chairman of the Board of Trustees of the Sanford Burnham Medical Research Institute.  He received his B.S. in Engineering from Pennsylvania State University and an M.B.A. from Harvard Business School.